Status:

COMPLETED

Neurofeedback and Nomophobia in Young Adults

Lead Sponsor:

University of Salamanca

Collaborating Sponsors:

Instituto de Investigación Biomédica de Salamanca

Gerencia Regional de Salud de Castilla y Leon

Conditions:

Anxiety

Biofeedback

Eligibility:

All Genders

18-30 years

Phase:

NA

Brief Summary

Introduction: Given the growing increase in addiction to social networks and smartphone use in young people and its implications for health, it is necessary to investigate effective interventions for ...

Eligibility Criteria

Inclusion

  • Have one or more mobile devices such as smartphones.
  • Have a compatible mobile device to install and use the Muse: EEG Meditation \& Sleep application.
  • Be fully functional.
  • Willingness to voluntarily participate in the study and sign the informed consent form.

Exclusion

  • History of severe psychiatric disorders (such as schizoaffective disorders, bipolar disorder, major depressive episode with symptoms or other non-organic psychotic disorders) requiring psychiatric treatment in the 6 months prior to study entry.
  • History of brain injury or other problems contraindicating the use of neurofeedback.

Key Trial Info

Start Date :

April 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06188910

Start Date

April 1 2024

End Date

February 28 2025

Last Update

September 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Salamanca

Salamanca, Salamanca, Spain, 37007